Nexalin Technology Inc (NXL) - News Archive

In an epoch characterized by rapid advancements in healthcare technology, Nexalin Technology Inc. has reached a pivotal milestone. The completion of Phase 1 of its innovative Virtual Clinic AI Components signifies a rem...

Nexalin Technology Reinstates Nasdaq Compliance with Minimum Bid Price Requirement HOUSTON, TX, November 1, 2024 - In a significant development for its financial standing and market perception, Nexalin Technology, Inc....

Nexalin Tech Sees Sharp Premarket Fall Amid Dilution FearsNexalin Technology (NASDAQ: NXL) experienced a significant drop in premarket trading, with its stock falling by 40%. The decline comes after the medical device c...

Nexalin Technology, a pioneering medical firm specializing in innovative approaches to mental health disorders, has recently published the highly anticipated results of a groundbreaking clinical trial in a leading scien...

This article sheds light on the recent developments surrounding Nexalin Technology Inc (NASDAQ: NXL), a medical device company focused on developing non-invasive therapies for various neurological disorders. By examinin...

By CSIMarket.com Reporter Nexalin Technology, a pioneering company in brain health solutions, has announced a significant milestone: the Brazilian Health Regulatory Agency (ANVISA) has approved the sale of its Gen-2, 15...

In an exciting development within the realm of anxiety and insomnia treatment, the U.S. Food and Drug Administration (FDA) recently provided valuable feedback and reached a consensus on the design of Nexalin s Gen-3 HAL...

Nexalin Technology: Pioneering Neurostimulation and Advancing Virtual Clinic ModelsAs technology continues to revolutionize the healthcare industry, Nexalin Technology emerges as a frontrunner in the field of neurostimu...